Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14055-37-9

Post Buying Request

14055-37-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14055-37-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 14055-37-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,0,5 and 5 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 14055-37:
(7*1)+(6*4)+(5*0)+(4*5)+(3*5)+(2*3)+(1*7)=79
79 % 10 = 9
So 14055-37-9 is a valid CAS Registry Number.

14055-37-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-cyclopent-3-en-1-ylacetaldehyde

1.2 Other means of identification

Product number -
Other names 3-Cyclopentene-1-acetaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14055-37-9 SDS

14055-37-9Relevant articles and documents

Preparation method and intermediate of fused tricyclic derivative

-

, (2020/08/27)

The invention provides a preparation method of a fused tricyclic derivative intermediate. The intermediate has a structure shown as a formula (4-7). The preparation method has the advantages of accessible raw materials and simple steps and is suitable for large-scale industrial production.

4-SUBSTITUTED IMIDAZOLE-2-THIONES AND IMIDAZOL- 2-ONES AS AGONISTS OF THE ALPHA- 2B AND ALPHA-2C ADRENERGIC RECEPTORS

-

, (2008/06/13)

Compounds of Formula (I): where X is S and the variables have the meaning defined in the specification are specific or selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors, and as such have no or only minimal cardivascular and/or sedatory activity. These compounds of Formula (I) are useful as medicaments in mammals, including humans, for treatment of diseases and or alleviations of conditions which are responsive to treatment by agonists of alpha2B adrenergic receptors. Compounds of Formula (I) where X is O also have the advantageous property that they have no or only minimal cardivascular and/or sedatory activity and are useful for treating pain and other conditions with no or only minimal cardivascular and/or sedatory activity.

Synthese und Hydrolyse von 6endo-substituierten p-Toluolsulfonsaeure-estern.

Grob, Cyril A.,Guenther, Bettina,Hanreich, Reinhard

, p. 2288 - 2298 (2007/10/02)

The Synthesis and Hydrolysis of 6endo-Substituted 2endo-Norbornyl p-Toluenesulfonates; The hydrolysis products of the p-toluenesulfonates of several hitherto unknown 6endo-substituted 2endo-norbornanols have been determined.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14055-37-9